Physician profile
Laura Bailey
NPI 1891115663
$1,515.35
in general payments reported to CMS, 2019-2025
17 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $185 · 2022: $706 · 2023: $326 · 2024: $176 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $625.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $366.64 | 2022-2023 | |
| Organogenesis INC. | $200.55 | 2022 | |
| Solventum Corporation | $137.21 | 2024-2025 | Activ.A.C., 3m Cavilon, V.A.C. Veraflo Cleanse Choice |
| Novo Nordisk INC | $122.13 | 2022 | |
| Idorsia Pharmaceuticals US INC | $104.57 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $82.55 | 2021 | |
| Alkermes, INC. | $82.19 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $77.98 | 2021-2022 | |
| Smith+Nephew, INC. | $64.16 | 2024-2025 | Collagenase Santyl |
| Neurocrine Biosciences, INC. | $58.59 | 2022 | |
| Bsn Medical INC | $51.41 | 2024-2025 | |
| Amgen INC. | $45.05 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.93 | 2023 | Jardiance |
| Molnlycke Health Care US, LLC | $27.37 | 2024 | Mepilex Border Flex |
| Advanced Respiratory, INC | $22.93 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $18.84 | 2024 | Nuzyra |
| Kci USA, INC. | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.